General form of registration statement for all companies including face-amount certificate companies

SCHEDULE OF SEGMENT INFORMATION (Details)

v3.24.2.u1
SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Product Information [Line Items]            
Net Revenue $ 2,397,652 $ 19,738 $ 4,804,043 $ 20,659 $ 2,532,499 $ 4,803
Total operating loss (2,087,798) (1,778,350) (4,033,028) (3,336,320) (7,973,228) (4,011,058)
Non-operating income (expense), net (17,062) 42,764 (29,975) 79,763 57,210 (4,140,596)
Net loss before income taxes (2,104,860) (1,735,586) (4,063,003) (3,256,557) (7,916,018) (8,151,654)
Income tax expense (5,419) (4,587) (9,091) (16,406) (20,993) (2,459)
Net Loss (2,110,279) (1,740,173) (4,072,094) (3,272,963) (7,937,011) (8,154,113)
Diagnostic R&D [Member]            
Product Information [Line Items]            
Net Revenue 4,038 6,923 19,442
Total operating loss (453,895) (370,384) (896,494) (759,629) (1,724,597) (1,524,170)
Laboratory Services [Member]            
Product Information [Line Items]            
Net Revenue 2,393,614 [1] 19,738 [1] 4,797,120 [1] 20,659 [1] 2,513,057 4,803
Total operating loss (2,535,285) (1,235) (5,272,284) (1,322) (3,769,783) (95,041)
General Corporate Activities [Member]            
Product Information [Line Items]            
Total operating loss $ (1,496,270) $ (1,426,469) $ (2,668,293) $ (2,596,028) $ (5,011,347) $ (2,396,650)
[1] The majority of the increase versus the prior year is from the acquisition of Precision Pathology Laboratories Services, LLC on September 18, 2023.